Harvard Business Review

OCTOBER 16, 2013

Say, toward venture capitalists pouring money into the next photo sharing app. First of all, venture capitalists tend to focus in a few places, in a few sectors. I think venture capitalists do play a role. And the American entrepreneurial economy is much broader than that.

Venture Capitalist 9

Venture Capitalist Company Biotechnology Transportation 9

Harvard Business Review

MARCH 11, 2014

It’s a common question thrown at me by entrepreneurs, venture capitalists, or the more cynically minded corporate leaders. Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants).

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

MAY 2, 2011

Last year, at the World Economic Forum's annual meeting in China, we spoke with one of the country's most celebrated scientists, entrepreneurs, and venture capitalists. Most technology ventures in China are of the C2C variety, i.e., Copy-To-China.

Globalization 13

Globalization Marketing Venture Capitalist Biotechnology 13

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). Editor's Note: This post was written with Justin Chakma, an undergraduate student at the University of Toronto (Canada).

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

OCTOBER 26, 2011

Many venture capitalists are limiting their investments to the "demand-side" — aimed at reducing energy use — rather than investing in startups trying to change the way we produce energy. Their behavior displays promising parallels to the early days of the biotechnology industry.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

MARCH 8, 2013

Venture capitalists entered only after government funding had gotten the company to the critical proof of concept. It is not by accident that the National Institutes of Health spends $31 billion a year on supporting innovation in biotechnology and pharmacology. It also received its early stage finance from the U.S.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Innovation 8

Harvard Business Review

JUNE 16, 2016

“Venture capitalists are looking for rapid exits and researchers are pretty much stuck with the idea that they came to the party with. Profit-driven companies, on the other hand, feel so much pressure to go to market that they often pass on ideas with vast potential.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8